Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Cell
|
May 15, 2002
PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2
Anil Kumar Bhunia, Klaus Piontek, Alessandra Boletta, et al.
Nature Communications
|
March 3, 2016
mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex
Monika Pema, Luca Drusian, Marco Chiaravalli, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 26, 2010
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases
Vicente E Torres, Alessandra Boletta, Arlene Chapman, et al.
Clinical and Experimental Nephrology
|
June 10, 2016
Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells
Lucia de Stephanis, Anna Bonon, Katia Varani, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
August 18, 2006
A regulatory role of polycystin-1 on cystic fibrosis transmembrane conductance regulator plasma membrane expression
Masahiro Ikeda, Peying Fong, Jie Cheng, et al.
Molecular and Cellular Biology
|
March 4, 2009
Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1
Gianfranco Distefano, Manila Boca, Isaline Rowe, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2002
Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations
Feng Qian, Alessandra Boletta, Anil K Bhunia, et al.
Journal of the American Society of Nephrology : JASN
|
November 5, 2015
2-Deoxy-d-Glucose Ameliorates PKD Progression
Marco Chiaravalli, Isaline Rowe, Valeria Mannella, et al.
EMBO Molecular Medicine
|
May 9, 2023
Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma
Giulio Donati, Paola Nicoli, Alessandro Verrecchia, et al.
Nature Medicine
|
March 26, 2013
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
Isaline Rowe, Marco Chiaravalli, Valeria Mannella, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Cell
|
May 15, 2002
PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2
Anil Kumar Bhunia, Klaus Piontek, Alessandra Boletta, et al.
Nature Communications
|
March 3, 2016
mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex
Monika Pema, Luca Drusian, Marco Chiaravalli, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 26, 2010
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases
Vicente E Torres, Alessandra Boletta, Arlene Chapman, et al.
Clinical and Experimental Nephrology
|
June 10, 2016
Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells
Lucia de Stephanis, Anna Bonon, Katia Varani, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
August 18, 2006
A regulatory role of polycystin-1 on cystic fibrosis transmembrane conductance regulator plasma membrane expression
Masahiro Ikeda, Peying Fong, Jie Cheng, et al.
Molecular and Cellular Biology
|
March 4, 2009
Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1
Gianfranco Distefano, Manila Boca, Isaline Rowe, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2002
Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations
Feng Qian, Alessandra Boletta, Anil K Bhunia, et al.
Journal of the American Society of Nephrology : JASN
|
November 5, 2015
2-Deoxy-d-Glucose Ameliorates PKD Progression
Marco Chiaravalli, Isaline Rowe, Valeria Mannella, et al.
EMBO Molecular Medicine
|
May 9, 2023
Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma
Giulio Donati, Paola Nicoli, Alessandro Verrecchia, et al.
Nature Medicine
|
March 26, 2013
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
Isaline Rowe, Marco Chiaravalli, Valeria Mannella, et al.
Page
of 7